首页> 外国专利> Pharmaceutical Combination comprising an Antibody that specifically recognizes to CD38, and Cyclophosphamide, where the Antibody is capable of eliminating a CD38 + cells by apoptosis, Antibody dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC).

Pharmaceutical Combination comprising an Antibody that specifically recognizes to CD38, and Cyclophosphamide, where the Antibody is capable of eliminating a CD38 + cells by apoptosis, Antibody dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC).

机译：药物组合，其包含特异性识别CD38的抗体和环磷酰胺，其中该抗体能够通过凋亡，抗体依赖性细胞介导的细胞毒性（ADCC）和补体依赖性细胞毒性（CDC）消除CD38 +细胞。

页面导航

摘要
著录项
相似文献

摘要

Pharmaceutical combinations comprising an Antibody that specifically recognizes at least CD38 and Cyclophosphamide; and use of CD38 Antibody that recognizes specifically for the treatment of squamoR.

机译：药物组合，其包含至少能特异性识别CD38和环磷酰胺的抗体;和CD38抗体的用途，该抗体专门用于治疗squamoR。

著录项

公开/公告号CL2011001256A1

专利类型
公开/公告日2012-01-27

原文格式PDF
申请/专利权人 SANOFI;
展开▼

申请/专利号CL20110001256
发明设计人 LEJEUNE PASCALE;VRIGNAUD PATRICIA;
展开▼

申请日2011-05-27
分类号A61K31/675;A61K39/395;A61P35/00+;
国家 CL
入库时间 2022-08-21 17:25:21

相似文献

专利
外文文献
中文文献